ARTIVION Files 8-K on Financial Results and Operations

TL;DR

ARTIVION just filed an 8-K on its financial results, but the actual numbers aren't in this snippet!

AI Summary

ARTIVION, INC. filed an 8-K on February 15, 2024, reporting on its results of operations and financial condition, along with financial statements and exhibits. The filing indicates that the earliest event reported also occurred on February 15, 2024. The company, formerly known as CRYOLIFE INC until May 26, 1994, is incorporated in Delaware and operates in the surgical and medical instruments sector.

Why It Matters

This filing signals that ARTIVION, INC. is providing updated financial information to the public, which is crucial for investors and analysts to assess the company's performance and health. While specific figures are not in this excerpt, the filing itself is a standard disclosure event.

Risk Assessment

Risk Level: low — The filing itself is a routine disclosure of financial results, and the provided text does not contain any information indicating unusual risks or significant events beyond standard reporting.

Key Numbers

• 7704193355 — Business Phone Number (Registrant's contact information)
• 001-13165 — SEC File Number (Company's SEC identification)
• 0000784199 — Central Index Key (CIK) (Company's unique identifier at SEC)

Key Players & Entities

• ARTIVION, INC. (company) — registrant
• CRYOLIFE INC (company) — former company name
• February 15, 2024 (date) — date of report and earliest event
• May 26, 1994 (date) — date of name change from Cryolife Inc
• Delaware (location) — state of incorporation
• Kennesaw, Georgia (location) — principal executive office

FAQ

Key Financial Figures

• $0.01 — nge on which registered Common Stock, $0.01 par value AORT NYSE Indicate by check

Filing Documents

• aort-20240215.htm (8-K) — 28KB
• aort-2023x8k123123ex991.htm (EX-99.1) — 442KB
• image.jpg (GRAPHIC) — 18KB
• 0000784199-24-000013.txt ( ) — 648KB
• aort-20240215.xsd (EX-101.SCH) — 2KB
• aort-20240215_lab.xml (EX-101.LAB) — 24KB
• aort-20240215_pre.xml (EX-101.PRE) — 13KB
• aort-20240215_htm.xml (XML) — 3KB

02 Results of Operations and Financial Condition

Item 2.02 Results of Operations and Financial Condition On February 15, 2024, Artivion, Inc. ("Artivion") issued a press release announcing its financial results for the fourth quarter ended December 31, 2023. Artivion hereby incorporates by reference herein the information set forth in its press release dated February 15, 2024, a copy of which is attached hereto as Exhibit 99.1. Except as otherwise provided in the press release, the press release speaks only as of the date of such press release and it shall not create any implication that the affairs of Artivion have continued unchanged since such date. The information provided pursuant to this Item 2.02 is to be considered "furnished" pursuant to Item 2.02 of Form 8-K and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended, nor shall it be deemed incorporated by reference into any of Artivion's reports or filings with the Securities and Exchange Commission, whether made before or after the date hereof, except as expressly set forth by specific reference in such report or filing. Except for the historical information contained in this report, the statements made by Artivion are forward-looking statements that involve risks and uncertainties. All such statements are subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. Artivion's future financial performance could differ significantly from the expectations of management and from results expressed or implied in the press release. Please refer to the last paragraph of the text portion of the press release for further discussion about forward-looking statements. For further information on risk factors, please refer to "Risk Factors" contained in Artivion's most recently filed Form 10-K and its subsequent filings with the Securities and Exchange

01(d) Exhibits

Item 9.01(d) Exhibits (d) Exhibits. Exhibit Number Description 99.1 * Press Release dated February 15, 2024. 104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). * Furnished herewith, not filed. -2-

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, Artivion, Inc. has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: February 15, 2024 ARTIVION, INC. By: /s/ Lance A. Berry Name: Lance A. Berry Title: Executive Vice President and Chief Financial Officer -3-

View Full Filing

View this 8-K filing on SEC EDGAR